Company builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity therapeutics market HYFT®-driven discovery supports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback